Caroline Bonmati Selected Research

Caroline Bonmati Research Topics

9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 12/2012
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 02/2011
4	Philadelphia Chromosome 01/2018 - 02/2011
3	Infections 12/2019 - 02/2011
2	Lymphoma (Lymphomas) 01/2022 - 12/2019
2	Thrombosis (Thrombus) 01/2020 - 11/2015
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2019 - 11/2014
1	Residual Neoplasm 12/2021
1	Acute Promyelocytic Leukemia 12/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Venous Thromboembolism 01/2020
1	Hemorrhage 01/2020
1	Agammaglobulinemia (Hypogammaglobulinemia) 12/2019
1	Pathologic Complete Response 11/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2015
1	Pancreatitis 09/2015
1	Hypersensitivity (Allergy) 09/2015
1	Tumor Lysis Syndrome 08/2013
1	Disseminated Intravascular Coagulation 08/2013
1	Acute Kidney Injury (Acute Renal Failure) 08/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2011
1	Thrombocytopenia (Thrombopenia) 02/2011
1	Neutropenia 02/2011
1	Bacteremia 02/2011

5	Asparaginase (Elspar)FDA Link 01/2020 - 09/2015
4	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2021 - 11/2016
2	Lomustine (CCNU)FDA Link 01/2021 - 11/2018
2	lipoarabinomannan (LAM)IBA 01/2021 - 11/2018
2	AntithrombinsIBA 01/2020 - 11/2015
2	Methotrexate (Mexate)FDA LinkGeneric 12/2019 - 11/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 02/2011
2	Rituximab (Mabthera)FDA Link 12/2019 - 11/2014
2	Inosine Triphosphate (ITP)IBA 12/2019 - 11/2014
2	Dasatinib (BMS 354825)FDA Link 11/2016 - 06/2015
1	gilteritinibIBA 01/2023
1	midostaurinIBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2021
1	CPX-351IBA 12/2021
1	Arsenic Trioxide (Trisenox)FDA Link 12/2021
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Prednisone (Sone)FDA LinkGeneric 12/2019
1	Vincristine (Oncovin)FDA LinkGeneric 12/2019
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2018
1	AnthracyclinesIBA 05/2017
1	Imatinib Mesylate (Gleevec)FDA Link 11/2016
1	Heparin (Liquaemin)FDA LinkGeneric 11/2015
1	Lipase (Acid Lipase)FDA Link 09/2015
1	Core Binding Factors (Core-Binding Factor)IBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2015
1	Oxidoreductases (Dehydrogenase)IBA 08/2013
1	Phosphates (Orthophosphate)IBA 08/2013
1	rasburicase (Elitek)FDA Link 08/2013
1	liposomal doxorubicin (Doxil)FDA Link 02/2011

8	Drug Therapy (Chemotherapy) 01/2023 - 11/2016
7	Therapeutics 12/2021 - 12/2012
1	Stem Cell Transplantation 01/2022
1	Homologous Transplantation 11/2018
1	Injections 11/2015
1	Induction Chemotherapy 11/2015
1	Erythrocyte Transfusion 02/2011